Drugs / Group A meningococcal polysaccharide vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials · 1 met primary | ||||||
| Phase 4 | NCT06209398 | May 2018 → Dec 2024 | hand, foot and mouth disease | Jiangsu Province Centers for Disease Control and Prevention | Unknown | No outcome recorded |
| Phase 4 | NCT03274102 | Apr → Nov 2017 | hand, foot and mouth disease | Sinovac Biotech Co., Ltd | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02601040 Comparator | Nov 2011 → Jun 2014 | hepatitis A virus infection | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2022-06-09 | Sinovac Biotech Co., Ltd | Results SINOVAC科兴EV71疫苗益尔来福 ® 上市六年来临床研究回顾 sinovac.com ↗ |
| 2019-04-08 | Sinovac Biotech Co., Ltd | Results 北京科兴EV71疫苗联合免疫研究成果受到国际广泛关注 sinovac.com ↗
结果表明联合免疫不会影响疫苗的免疫原性和安全性。 |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2022-06-09 | Sinovac Biotech Co., Ltd | SINOVAC科兴EV71疫苗益尔来福 ® 上市六年来临床研究回顾 sinovac.com ↗ |
| 2019-04-08 | Sinovac Biotech Co., Ltd | 北京科兴EV71疫苗联合免疫研究成果受到国际广泛关注 sinovac.com ↗ |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Group A meningococcal polysaccharide vaccine | “Group A meningococcal polysaccharide vaccine (subcutaneous injection, 150ug) on day 30” NCT03274102 ↗ |
| Known as | MenA | “This study tested the hypothesis that the immunogenicity and safety of the simultaneous administration of enterovirus 71 (EV71) vaccine (dose 1) with recombinant hepatitis B...” PMID 30891604 ↗ Jul 2019 |
| Modality | Vaccine | “group A meningococcal polysaccharide vaccine (MenA)” PMID 30891604 ↗ Jul 2019 |
| Route | Intramuscular | “Group A Meningococcal Polysaccharide vaccine intramuscularly in the deltoid region.” NCT02601040 ↗ |